## CNC: Centene Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 1.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Molina Healthcare, Inc $MOH Shares Purchased by Swedbank AB**
- Source: MarketBeat | 20251227T110828 | Neutral | Relevance: 65%
- Swedbank AB increased its holdings in Molina Healthcare, Inc (MOH) by 8.2% in the third quarter, acquiring an additional 8,416 shares to own a total of 110,592 shares valued at approximately $21.16 million. Despite institutional investors owning 98.5% of the stock, analysts have a "Hold" rating with an average price target of $196.33, after the company reported a significant quarterly EPS miss and provided lower-than-expected FY2025 guidance.

**2. ZeOmega Recognized in 2025 Gartner(R) Market Guide for U.S. Healthcare Payer Care Management Workflow Applications**
- Source: Shreveport Times | 20251227T070847 | Somewhat-Bullish | Relevance: 65%
- ZeOmega has been recognized as a "Visionary Incumbent" in the 2025 Gartner Market Guide for U.S. Healthcare Payer Care Management Workflow Applications, a recognition they believe highlights their efforts to modernize payer care management amid evolving regulatory and technological demands. The company's Jiva Population Health Enterprise Management Platform addresses critical needs in healthcare by leveraging AI and analytics to automate workflows, identify at-risk populations, facilitate data exchange, and enhance member engagement. This acknowledgment affirms ZeOmega's commitment to providing advanced solutions that help health plans adapt to shifting policies, clinical standards, and member expectations, ultimately driving better outcomes.

**3. Ethic Inc. Reduces Holdings in Elevance Health, Inc. $ELV**
- Source: MarketBeat | 20251229T101334 | Neutral | Relevance: 64%
- Ethic Inc. reduced its stake in Elevance Health, Inc. (NYSE:ELV) by 17.0% in Q3, selling 6,761 shares and holding 33,008 shares valued at approximately $10.67 million. Despite this reduction, several other institutional investors increased their positions in ELV during recent quarters. Elevance Health reported strong Q3 earnings, beating analyst estimates with an EPS of $6.03 and revenue of $50.09 billion, and it maintains a "Moderate Buy" consensus rating from analysts with an average price target of $396.21.

**4. Molina Healthcare, Inc $MOH Shares Sold by Voya Investment Management LLC**
- Source: MarketBeat | 20251228T132351 | Neutral | Relevance: 63%
- Voya Investment Management LLC significantly reduced its stake in Molina Healthcare, Inc ($MOH) by 52.8% in Q3, selling 14,357 shares and retaining 12,857 shares valued at $2.46 million. This reduction comes as Molina reported Q3 EPS of $1.84, missing analyst estimates, despite revenue beating expectations. The company's stock currently holds an average "Hold" rating from analysts with an average price target of $196.33.

**5. Cwm LLC Purchases 59,690 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251228T090534 | Neutral | Relevance: 63%
- Cwm LLC significantly increased its stake in Molina Healthcare (NYSE:MOH) by 364.9%, acquiring 59,690 additional shares to own a total of 76,049 shares valued at approximately $14.55 million. This move comes as Molina Healthcare reported a quarterly EPS miss but an 11% revenue increase, with analysts maintaining a "Hold" rating and an average price target of $196.33 for the stock.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($2.58M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (-2.8%)
- Blackrock Inc.: 9.2% (+0.3%)
- State Street Corpora: 4.3% (-7.7%)
- AQR Capital Manageme: 3.0% (+76.6%)
- Geode Capital Manage: 2.6% (-4.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Forward P/E 14.1x attractive for 42% earnings growth. Balance sheet: $1.1B free cash flow. Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.1B |
| Beta | 0.48 |
| 52W Range | $25.08 - $66.81 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 14.1 |
| Current P/E | 20.1 |
| YoY Growth | 42.3% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 0.5% to 1.9% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. Below SMA200 (0.95x), long-term trend not supportive. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.93% (CS: 94) | Neutral |
| RSI_14 | 62.0 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.092x | Above |
| vs SMA200 | 0.950x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.83
- **Stop Loss:** $38.39 (6.0% risk)
- **Target:** $43.27 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 565
- **Position Value:** $23,068.95
- **Portfolio %:** 23.07%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $-1.19)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.16 | $0.50 | +404.3% |
| 2025Q2 | $0.21 | $-0.16 | -177.3% |
| 2025Q1 | $2.52 | $2.90 | +15.3% |
| 2024Q4 | $0.49 | $0.80 | +62.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*